Critically Karunas submission came before Oct 1 when hard line Republicans may force a government shutdown that prevents the FDA from accepting new applications. By acting now Karuna should get an answer from regulators around this time next year RBC Capital Markets analyst Brian Abrahams wrote in a note to clients